🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tobias Wunberg

Roche (United States)

ORCID: 0000-0001-6521-8201

Also affiliated with Boehringer Ingelheim (Germany), Boehringer Ingelheim (Austria), Boehringer Ingelheim (India)

Biochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRAS G12C Inhibitor”.

Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRAS G12C Inhibitor

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.2c01120
N/A
0.663DataRank · unranked
82 citations

Alex G. Waterson, Chris A. Smethurst, Dirk Kessler, Jark Böttcher, Moriz Mayer +22 more

Pan-KRAS inhibitor disables oncogenic signalling and tumour growth

Nature(2023)10.1038/s41586-023-06123-3
N/A
0DataRank · unranked
506 citations

Lorenz Herdeis, Dorothea Rudolph, Yulei Zhao, Jark Böttcher, Alberto Vides +19 more

Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In Vivo Activities in Mouse Models of Hematological and Solid Tumors

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.4c01188
N/A
0DataRank · unranked
17 citations

James M. Salovich, Martin Aichinger, KyuOk Jeon, Nagarathanam Veerasamy, John Sensintaffar +22 more

Discovery of BI-2493, a Pan-KRAS Inhibitor Showing In Vivo Efficacy

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.5c00576
N/A
0DataRank · unranked
10 citations

Alex G. Waterson, Timothy R. Hodges, Jason R. Abbott, Allison L. Arnold, Jark Böttcher +20 more